Pasithea Therapeutics Corp. (KTTA) at a glance

Pasithea Therapeutics Corp. (KTTA) is a micro-cap Healthcare company. It trades at $0.54, with a 0% profit margin. It does not pay a dividend. Vestovix scores it 57/100 overall. Its strongest dimension is Safety (99/100) and its weakest is Momentum (23/100). It is a relatively defensive holding with below-market volatility.

Price

$0.54

Market cap

$19.8M

P/E ratio

n/a

Dividend yield

None

Beta

0.25

52-week range

$0.28 to $2.06